Mixing Covid vaccines gives good protection: Study

June 29, 2021 00:52

A mix-and-match approach to COVID-19 vaccines -- using different brands of jab for first and second doses -- gives good protection against the pandemic virus, a UK study has found.

The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other.

All combinations worked well, priming the immune system, the BBC quoted the study as saying on Monday.

This knowledge could offer flexibility for vaccine rollout, the report quoted experts as saying.

The UK's deputy chief medical officer, Prof Jonathan Van-Tam, said there was no reason to change the current successful same dose vaccine schedules in the UK, however, given vaccines were in good supply and saving lives.

But he says it might be something to look at in the future: "Mixing doses could provide us with even greater flexibility for a booster programme, while also supporting countries who have further to go with their vaccine rollouts, and who may be experiencing supply difficulties."

Two doses are important to give the fullest protection and teach the body to make antibodies and T cells to block and kill the deadly virus.

Some countries are already using mixed doses. Spain and Germany are offering the Pfizer or Moderna mRNA vaccines as a second dose to younger people who have already received a first dose of the AstraZeneca vaccine, following concerns about rare but serious blood clots, rather than about efficacy.

The Com-Cov study, which looked at giving the doses four weeks apart in 850 volunteers aged 50 and above, found that an AstraZeneca jab followed by Pfizer induced higher antibodies and T cell responses than Pfizer followed by AstraZeneca.

Both of these mixes induced higher antibodies than two doses of AstraZeneca, the report said.

The highest antibody response was seen after two doses of Pfizer, and the highest T cell response from AstraZeneca followed by Pfizer, it said.

« Back to LIVE

TOP STORIES

What's Bipasha Celebrating?

Film folk have been celebrating these last few days. Here's looking at just how.

SC registry refuses to accept Centre's plea on 2G verdict

The Supreme Court Registry is learnt to have refused to accept the Centre's plea seeking modification of its 2012 verdict in the 2G spectrum case which had said the State was duty bound to adopt the auction route while transferring or...

Wage Pact: Will Bankers Make More Money?

Postings to places at an altitude above 1,000 metres but less than 1,500 metres, between 1,500 and 3,000 metres, and above 3,000 metres entail different rates of allowances -- the higher the location, the bigger the allowance, reveals...

Remembering Ayrton Senna 30 Years On

F1 fans remember Formula One legend Ayrton Senna da Silva on his 30th death anniversary, May 1 2024.

Manufacturing sector activity moderated in April, but...

India's manufacturing sector activity moderated in April, but still recorded the second fastest improvement in operating conditions in three-and-a-half years supported by buoyant demand, a monthly survey said on Thursday.